Hauss D J, Ando H Y, Grasela D M, Sugita E T
Department of Pharmaceutics, Philadelphia College of Pharmacy & Science, PA 19104.
J Pharmacobiodyn. 1991 Mar;14(3):139-51. doi: 10.1248/bpb1978.14.139.
The sodium salts of the 3,5-dichloro, 3,5-dibromo-, 3,5-diiodo-, and 5-methoxy- analogs of salicylic acid have been evaluated as enhancers of rectal insulin absorption. A relationship was found between adjuvant potency and relative lipophilicity. Maximal adjuvant activity was obtained with 0.1 M 3,5-dichlorosalicylate. Higher concentrations (0.15 M) of 3,5-diiodosalicylate produced a decline in adjuvant activity, which may be associated with extraction of specific cellular proteins. This may indicate the existence of an optimal salicylate lipophilicity for adjuvant efficacy. Relative adjuvant activity was found to be related to the lymph:plasma absorption ratio of [125I]insulin. Lymphatic uptake of insulin was not related to lymph flow rate.
水杨酸的3,5 - 二氯、3,5 - 二溴、3,5 - 二碘和5 - 甲氧基类似物的钠盐已被评估为直肠胰岛素吸收的增强剂。发现佐剂效力与相对亲脂性之间存在关系。用0.1M的3,5 - 二氯水杨酸盐可获得最大的佐剂活性。较高浓度(0.15M)的3,5 - 二碘水杨酸盐会导致佐剂活性下降,这可能与特定细胞蛋白的提取有关。这可能表明存在佐剂功效的最佳水杨酸盐亲脂性。发现相对佐剂活性与[125I]胰岛素的淋巴:血浆吸收比有关。胰岛素的淋巴摄取与淋巴流速无关。